Angiopoietin-like protein 8
The ANGPTL8 gene encodes an inhibitor of lipolysis. Therefore it is a probably candidate for mutation in hypertriglyceridemia.
Genetests:
Related Diseases:
References:
1. |
Cefalù AB et al. () Identification of a novel LMF1 nonsense mutation responsible for severe hypertriglyceridemia by targeted next-generation sequencing.
|
2. |
None (2012) Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels.
|
3. |
Quagliarini F et al. (2012) Atypical angiopoietin-like protein that regulates ANGPTL3.
|
4. |
Tseng YH et al. (2014) Chromosome 19 open reading frame 80 is upregulated by thyroid hormone and modulates autophagy and lipid metabolism.
|
5. |
Gusarova V et al. (2014) ANGPTL8/betatrophin does not control pancreatic beta cell expansion.
|
6. |
NCBI article
NCBI 55908
|
7. |
OMIM.ORG article
Omim 616223
|
8. |
Wikipedia article
Wikipedia EN (ANGPTL8)
|
Update: Aug. 14, 2020